DNA polymerase β deficiency promotes the occurrence of esophageal precancerous lesions in mice Jiace Qin et al, 2021, Neoplasia CrossRef
An In-silico Approach: Design, Homology Modeling, Molecular Docking, MM/GBSA Simulations, and ADMET Screening of Novel 1,3,4-oxadiazoles as PLK1inhibitors null Revanasiddappa BC et al, 2023, Current Drug Research Reviews CrossRef
The Analysis of the Anti-Tumor Mechanism of Ursolic Acid Using Connectively Map Approach in Breast Cancer Cells Line MCF-7
Weiqiang Guo et al, 2020, Cancer Management and Research CrossRef
Identifying M1-like macrophage related genes for prognosis prediction in lung adenocarcinoma based on a gene co-expression network Zhiyuan Wang et al, 2023, Heliyon CrossRef
The Inhibitory Role of miR-486-5p on CSC Phenotype Has Diagnostic and Prognostic Potential in Colorectal Cancer Andrea Pisano et al, 2020, Cancers CrossRef
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance Elodie Montaudon et al, 2020, Nature Communications CrossRef
LFM-A13, a potent inhibitor of polo-like kinase, inhibits breast carcinogenesis by suppressing proliferation activity and inducing apoptosis in breast tumors of mice Kazim Sahin et al, 2018, Investigational New Drugs CrossRef
Therapeutic opportunities for PLK1 inhibitors: Spotlight on BRCA1-deficiency and triple negative breast cancers Iris Alejandra García et al, 2020, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis CrossRef
Iron‐Confined CRISPR/Cas9‐Ribonucleoprotein Delivery System for Redox‐Responsive Gene Editing Lingling Qiu et al, 2024, Small CrossRef
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer Ai Ueda et al, 2019, Laboratory Investigation CrossRef
Polo‐like kinase‐1 immunoreactivity is associated with metastases in cutaneous melanoma Maciej Kaczorowski et al, 2017, Journal of Cutaneous Pathology CrossRef
The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor? Guillermo de Cárcer, 2019, Genes CrossRef
Augmented expression of polo-like kinase 1 indicates poor clinical outcome for breast patients: a systematic review and meta-analysis Yunfeng Zhang et al, 2017, Oncotarget CrossRef
Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells Masahisa Kudo et al, 2022, Cell Death & Differentiation CrossRef
GSK461364A suppresses proliferation of gastric cancer cells and induces apoptosis Dilara Ataseven et al, 2023, Toxicology in Vitro CrossRef
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy Gianluca Santamaria et al, 2023, Cancer Drug Resistance CrossRef
Characteristics and prognostic significance of polo‐like kinase‐1 (PLK1) expression in breast cancer Ayat G Lashen et al, 2023, Histopathology CrossRef
CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses Felice Maria Accattatis et al, 2023, Nutrients CrossRef
The mitotic regulator polo‐like kinase 1 as a potential therapeutic target for c‐Myc‐overexpressing canine osteosarcomas Cecilia Gola et al, 2022, Veterinary and Comparative Oncology CrossRef
The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis Hefei Li et al, 2017, Bioscience Reports CrossRef
PLK1, A Potential Target for Cancer Therapy Zhixian Liu et al, 2017, Translational Oncology CrossRef
PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis Lilia Gheghiani et al, 2021, Cancer Research CrossRef
Calein C, a Sesquiterpene Lactone Isolated From Calea Pinnatifida (Asteraceae), Inhibits Mitotic Progression and Induces Apoptosis in MCF-7 Cells Lhaís Araújo Caldas et al, 2018, Frontiers in Pharmacology CrossRef